Safety and efficacy of patients with high risk and elevated minimal residual disease after allogeneic hematopoietic stem cell transplantation treated with interferon in combination with interleukin-2 regimen.
10.3760/cma.j.issn.0253-2727.2019.03.015
- VernacularTitle:干扰素联合白细胞介素2治疗异基因造血干细胞移植术后高危及微小残留病升高患者疗效及安全性观察
- Author:
Hao AI
1
;
Yue Wen FU
;
Qian WANG
;
Xu Dong WEI
;
Yong Ping SONG
Author Information
1. Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
- Publication Type:Journal Article
- From:
Chinese Journal of Hematology
2019;40(3):238-242
- CountryChina
- Language:Chinese
